Clinical Trial Update: A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402 [Phase 1]

View source ↗

Summary

A Phase 1 leukapheresis trial in healthy US adults examined immune responses after BCG vaccination followed by boosting with the AERAS-402 TB vaccine; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• AERAS-402
• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: Aeras | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED